Smad3, a major transcription factor in transforming growth factor-β (TGF-β) signaling, plays critical roles in both tumor-suppressive and pro-oncogenic functions. Upon TGF-β stimulation, the C-terminal tail of Smad3 undergoes phosphorylation that is essential for canonical TGF-β signaling. The Smad3 linker region contains serine/ threonine phosphorylation sites and can be phosphorylated by intracellular kinases, such as the MAPK family, cyclin-dependent kinase (CDK) family and glycogen syn- 
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Smad3, a major transcription factor in transforming growth factor-β (TGF-β) signaling, plays critical roles in both tumor-suppressive and pro-oncogenic functions. Upon TGF-β stimulation, the C-terminal tail of Smad3 undergoes phosphorylation that is essential for canonical TGF-β signaling. The Smad3 linker region contains serine/ threonine phosphorylation sites and can be phosphorylated by intracellular kinases, such as the MAPK family, cyclin-dependent kinase (CDK) family and glycogen synthase kinase-3β (GSK-3β). Previous reports based on cell culture studies by us and others showed that mutation of Smad3 linker phosphorylation sites dramatically intensifies TGF-β responses as well as growth-inhibitory function and epithelial-mesenchymal transition (EMT), suggesting that Smad3 linker phosphorylation suppresses TGF-β transcriptional activities. However, recent discoveries of Smad3-interacting molecules that preferentially bind phosphorylated Smad3 linker serine/threonine residues have shown a multitude of signal transductions that either enhance or suppress TGF-β responses associated with Smad3 turnover or cancer progression. This review aims at providing new insight into the perplexing mechanisms of TGF-β signaling affected by Smad3 linker phosphorylation and further attempts to gain insight into elimination and protection of TGF-β-mediated oncogenic and growth-suppressive signals, respectively.
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| INTRODUC TI ON
Transforming growth factor-β (TGF-β)/Smad3 signaling plays critical roles in a wide variety of biological processes and carries out multiple functions such as growth arrest, apoptosis, differentiation, and epithelial-mesenchymal transition (EMT). [1] [2] [3] [4] Studies using mouse embryonic fibroblasts with targeted disruption of either Smad2 or Smad3 showed that Smad3 plays significant roles in TGF-β-mediated transcriptional responses. 5, 6 A critical part of Smad3 in TGF-β-induced EMT also stems from observations that Smad3 knockout mice abrogate EMT in response to epithelial injuries in vivo or by exposure to TGF-β in cell culture. 7, 8 TGF-β has been reported to be suppressive in the early development of cancer, while acquiring cancer-promoting propensities in the later stages. TGF-β is abundantly expressed in most cancer tissues, and high levels of TGF-β often bode for adverse clinical outcomes. Figure 1A ).
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16 TGF-β signals, therefore, are mediated through a wide array of intracellular pathways through cross-talks, including a predominant Smad pathway as well as non-Smad, non-canonical pathways. [18] [19] [20] TGF-β signaling is tightly controlled and plays critical roles in embryogenesis and organogenesis together with the maintenance of cellular homeostasis. Perturbation of TGF-β signaling, therefore, causes life-threatening disorders such as cancer, organ fibrosis, and congenital malformations.
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| S MAD3 PHOS PHORYL ATI ON AT S ERINE/ THREONINE RE S IDUE S IN THE C-TERMINAL AND THE LINK ER REG I ON S
Smad3 linker serine/threonine phosphorylation sites except S213 are subject to phosphorylation in response to TGF-β ( Figure 1B ). in culture was first treated with a pan-CDK inhibitor, flavopiridol.
TGF-β transcriptional activity was significantly upregulated by treatment with flavopiridol concomitant with reduction of Smad3 linker phosphorylation at T179, S204, and S208, suggesting that Smad3 F I G U R E 1 Smad3 linker phosphorylation by intracellular kinases attenuates transforming growth factor-β (TGF-β)-induced Smad3 transcriptional activity. A, Serine/threonine residues at Smad3 C-terminal and linker region are depicted together with responsible kinases, including CDK family, ERK, JNK, p38 MAPK, and glycogen synthase kinase-3β (GSK-3β). TGF-β induces Smad3 phosphorylation at three sites in the linker region, threonine 179 (T179), serine 204 (S204), and serine 208 (S208), along with the two C-terminal residues, serine 423 (S423) and serine 425 (S425). Even in the absence of TGF-β, the linker region in cancer cells often becomes phosphorylated at a certain level (pink) by intracellular kinases that are constitutively activated, but less weakly as compared to that in the presence of TGF-β (red). B, In the breast cancer cell line (MCF-10CA1a.cl1, hereafter CA1a), treatment with a pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol lowered levels of TGF-β-induced Smad3 linker phosphorylation at T179, S204, and S208. Although CDK family does not directly phosphorylate S204, it can provide a priming site (pS208) for phosphorylation by GSK-3. GSK-3 is responsible for phosphorylation at S204. Flavopiridol, therefore, can reduce the level of GSK-3β-catalyzed phosphorylation at S204 together with that of CDK-catalyzed phosphorylation at T179, S208, and S213 (not shown). Level of Smad3 linker phosphorylation is inversely correlated with TGF-β-induced Smad3 transcriptional activity. EGF, epidermal growth factor; FGF, fibroblast growth factor; HGF, hepatocyte growth factor; IGF, insulin-like growth factor; PDGF, platelet-derived growth factor linker phosphorylation negatively regulates Smad3 transcriptional activity as determined by (CAGA) 12 -luciferase ([CAGA] 12 -Luc) reporter assay ( Figure 1B ). 23 Likewise, inhibition of Smad3 linker phosphorylation by a specific phosphatase (SCP1) acting on the Smad2/3 linker region has resulted in upregulation of TGF-β signaling.
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| MUTATI ON AT S MADLINK ER PHOS PHORYL ATI ON S ITE S G RE ATLY ENHAN CE S TG F-β S IG NALING
It was initially reported that Ras-induced Smad2/3 linker phosphorylation inhibits TGF-β-induced responses by interrupting nuclear translocation of Smad2/3 and subsequent Smad-dependent transcription. . 23 The magnitude of these changes is much Although EGF phosphorylates Smad3 linker serine/threonine residues, Pin1 is unable to recognize the phosphorylated linker sites of Smad3, indicating that C-terminal phosphorylation by TGF-β is essential for interaction with Pin1. 31 In a separate report, Pin1 has been shown to promote interaction of linker-phosphorylated Smad3 with a cofactor Olig1 and accelerate TGF-β-induced cell motility but neither growth arrest nor EMT. 32 Transforming growth factor-β signaling is known to be regulated by the ubiquitin-proteasome system. It has previously been reported that Pin1 binds preferentially to phosphorylated Smad2 and 3 at the linker region and enhances their interaction with Smad ubiquitination regulatory factor 2 (Smurf2), leading to proteasomal degradation of Smad2 and 3 by poly-ubiquitination ( Figure 4C ). 
| LINKER REG ION -PHOS PHORYL ATED S MAD3 RECRUITS FUN C TIONAL MOLECULE S THAT EITHER SUPPRE SS TG F-β S I G NALING OR PROMOTE TG F-β -INDUCED C AN CER PROG RE SS I ON
| MECHANIS TI C IN S I G HT INTO EMT AND C AN CER ME TA S TA S IS
Cancer progression and acquisition of malignant properties are often associated with accumulation of genetic mutations that often lead to 
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It has previously been reported that active Ras is required for induction of TGF-β-induced EMT in keratinocytes. 40 In pancreatic cancer cells, transfection of oncogenic Ras has markedly enhanced expression of Snail1, a critical mediator for EMT. However, the synergism between TGF-β and active Ras is confined to the expression of Snail1 but not any of other TGF-β target genes such as Smad7. 41 From our previous work, it can be speculated that onco- 
| CON CLUD ING REMARK S AND PER S PEC TIVE S
Smad3 signaling is mediated through multiple cross-talks between the canonical-and non-canonical pathways in a cell contextdependent way. A previous report by others showed that inhibition of CDK4/6 by a highly specific inhibitor induces TGF-β-induced EMT and enhances invasiveness of pancreatic cell lines, while significantly suppressing cell growth. 43 In melanoma cells, suppression of Smurf2 by RNA interference was reported to increase the cytotoxic effects F I G U R E 5 Smad3 linker phosphorylation modulates transforming growth factor-β (TGF-β)-induced epithelial-mesenchymal transition (EMT), metastasis, and cancer progression mediated through Smad3-and non-Smad3 signaling pathways. Phosphorylated Smad3 linker serine/threonine residues (shown by ○○○○) provide binding sites for peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (Pin1), neural precursor cell expressed developmentally downregulated gene 4-like (Nedd4L), Smad ubiquitin regulatory factor 2 (Smurf2), and poly(rC)-binding protein 1 (PCBP1). Active complexes thus formed regulate transforming growth factor-β (TGF-β) signaling and cancer progression. Pin1 enhances TGF-β responses transiently or promotes cell migration. Nedd4L induces Smad3 proteasomal degradation by polyubiquitination. Pin1 further facilitates the binding of Smurf2 and Smad3, leading to poly-ubiquitination-mediated degradation. Smurf2 also suppresses formation of the Smad3 complex with Smad4 by mono-ubiquitination of Smad3, leading to suppression of TGF-β signaling. The PCBP1-Smad3 complex promotes alternative splicing and produces varied gene products, including CD44s, which favor cancer progression and metastasis. Arrow-and hammer-headed lines indicate activation and inhibition, respectively, in signaling networks. CDK, cyclindependent kinase; EGF, epidermal growth factor; FGF, fibroblast growth factor; GSK-3β, glycogen synthase kinase-3β; HGF, hepatocyte growth factor; IGF, insulin-like growth factor; PDGF, platelet-derived growth factor of mitogen-activated protein kinase (MAPK) inhibition by sensitizing the TGF-β signaling. 44 These findings underscore the signifi- 
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